Disc Medicine, Inc. (IRON)
Total Valuation
Disc Medicine has a market cap or net worth of $644.07 million. The enterprise value is $408.91 million.
| Market Cap | 644.07M |
| Enterprise Value | 408.91M |
Important Dates
The last earnings date was Monday, May 15, 2023, before market open.
| Earnings Date | May 15, 2023 |
| Ex-Dividend Date | n/a |
Share Statistics
Disc Medicine has 19.80 million shares outstanding. The number of shares has increased by 1,951.95% in one year.
| Shares Outstanding | 19.80M |
| Shares Change (YoY) | +1,951.95% |
| Shares Change (QoQ) | +1,723.48% |
| Owned by Insiders (%) | 16.10% |
| Owned by Institutions (%) | 79.21% |
| Float | 7.47M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.77 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 24.26, with a Debt / Equity ratio of 0.01.
| Current Ratio | 24.26 |
| Quick Ratio | n/a |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
Financial Efficiency
Return on equity (ROE) is -35.00%.
| Return on Equity (ROE) | -35.00% |
| Return on Assets (ROA) | -32.80% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.07M |
| Employee Count | 51 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Disc Medicine has paid $23,000 in taxes.
| Income Tax | 23,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +166.64% in the last 52 weeks.
| Beta (1Y) | n/a |
| 52-Week Price Change | +166.64% |
| 50-Day Moving Average | 27.66 |
| 200-Day Moving Average | 20.68 |
| Average Volume (30 Days) | 111,222 |
Short Selling Information
The latest short interest is 304,738, so 1.54% of the outstanding shares have been sold short.
| Short Interest | 304,738 |
| Short Previous Month | 314,503 |
| Short % of Shares Out | 1.54% |
| Short % of Float | 4.08% |
| Short Ratio (days to cover) | 2.20 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -57.42M |
| Pretax Income | -54.35M |
| Net Income | -54.38M |
| EBITDA | -54.01M |
| EBIT | -54.42M |
| Earnings Per Share (EPS) | -$42.75 |
Balance Sheet
The company has $236.42 million in cash and $1.26 million in debt, giving a net cash position of $235.16 million or $11.88 per share.
| Cash & Cash Equivalents | 236.42M |
| Total Debt | 1.26M |
| Net Cash | 235.16M |
| Net Cash Per Share | $11.88 |
| Equity / Book Value | 232.86M |
| Book Value Per Share | 11.76 |
| Working Capital | 232.16M |
Cash Flow
In the last 12 months, operating cash flow was -$61.38 million and capital expenditures -$180,000, giving a free cash flow of -$61.56 million.
| Operating Cash Flow | -61.38M |
| Capital Expenditures | -180,000 |
| Free Cash Flow | -61.56M |
| FCF Per Share | -$3.25 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Disc Medicine does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Earnings Yield | -8.44% |
| FCF Yield | -9.56% |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1,951.95% |
| Shareholder Yield | -1,951.95% |
Analyst Forecast
The average price target for Disc Medicine is $40.14, which is 23.39% higher than the current price. The consensus rating is "Buy".
| Price Target | $40.14 |
| Price Target Difference | 23.39% |
| Analyst Consensus | Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | -34.19% |
Stock Splits
The last stock split was on December 30, 2022. It was a reverse split with a ratio of 1:30.
| Last Split Date | Dec 30, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:30 |